Song Hong Fang
CIK: 0002008157
Song Hong Fang's purchase track record
Song Hong Fang has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/29/2024 | CGON | $5.00M | +17.1% | -15.3% | +10.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CGON | ▼ Sell | Open Market | 69,695 | $1.9M | 9/3/2025 | View on chart |
| CGON | ▼ Sell | Open Market | 30,105 | $850K | 9/3/2025 | View on chart |
| CGON | ▼ Sell | Open Market | 100 | $3K | 9/3/2025 | View on chart |
| CGON | ▼ Sell | Open Market | 100 | $3K | 9/3/2025 | View on chart |
| CGON | ▼ Sell | Open Market | 700,000 | $19.6M | 12/16/2024 | View on chart |
| CGON | ▼ Sell | Open Market | 424,210 | $15.0M | 8/29/2024 | View on chart |
| CGON | ▼ Sell | Open Market | 226,245 | $8.0M | 8/29/2024 | View on chart |
| CGON | ▼ Sell | Other | 350,771 | — | 1/29/2024 | View on chart |
| CGON | ▼ Sell | Other | 1,011,192 | — | 1/29/2024 | View on chart |
| CGON | ▼ Sell | Other | 3,930,176 | — | 1/29/2024 | View on chart |
| CGON | ▲ Buy | Open Market | 263,157 | $5.0M | 1/29/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
CG Oncology appoints Isabel Kalefonos as Chief Commercial Officer
CG Oncology announced the appointment of Isabel Kalefonos as its new chief commercial officer. The hire adds experienced biopharmaceutical leadership as the company prepares for a possible bladder cancer product launch. The addition may strengthen the commercial strategy ahead of upcoming market activities.
CG Oncology appoints Isabel Kalefonos as Chief Commercial Officer. CG Oncology announced the appointment of Isabel Kalefonos as its new chief commercial officer. The hire adds experienced biopharmaceutical leadership as the company prepares for a possible bladder cancer product launch. The addition may strengthen the commercial strategy ahead of upcoming market activities.